BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24305518)

  • 41. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
    Sharma AM; Bakris G; Neutel JM; Littlejohn TW; Kobe M; Ting N; Ley L
    Clin Ther; 2012 Mar; 34(3):537-51. PubMed ID: 22386829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fixed combination of telmisartan and amlodipine. Lowering blood pressure with dual power].
    MMW Fortschr Med; 2010 Nov; 152(44):100-1. PubMed ID: 21158187
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.
    Wang JG; Pimenta E; Chwallek F
    Vasc Health Risk Manag; 2014; 10():189-200. PubMed ID: 24741317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2).
    Parati G; Bilo G; Redon J;
    Hypertens Res; 2013 Apr; 36(4):322-7. PubMed ID: 23154590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
    Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T
    Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
    Arif AF; Kadam GG; Joshi C
    J Indian Med Assoc; 2009 Oct; 107(10):730-3. PubMed ID: 20469750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telmisartan provides superior BP reduction from morning to morning compared to other leading ARBs.
    Cardiovasc J S Afr; 2006; 17(4):210. PubMed ID: 17001428
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
    Negro R; Hassan H
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):243-6. PubMed ID: 17318795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S; Edwards C; Jones R;
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1499-503. PubMed ID: 22103868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats.
    Lee JJ; Shin CY; Park HJ; Zhang WY; Kim Y; Kim IS; Lee KH; Myung CS
    Arch Pharm Res; 2010 Sep; 33(9):1411-8. PubMed ID: 20945140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.